| RS138374817 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Inborn genetic diseases |
| RS138374956 |
MMUT
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS1383756739 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS138376436 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Developmental and epileptic encephalopathy 6B |
| RS138376525 |
SLC25A19
|
Health Risk |
Conflicting classifications of pathogenicity |
Amish lethal microcephaly, SLC25A19-related disorder |
| RS1383769505 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS138376962 |
XIRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138376967 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, CIITA-related disorder |
| RS1383770460 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS138377835 |
HARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3B, Usher syndrome type 3B |
| RS138378067 |
FUCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fucosidosis, Inborn genetic diseases |
| RS1383783171 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1383783174 |
HECW2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS138378695 |
DLL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndactyly, Spondylocostal dysostosis 1 |
| RS138379032 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS138379074 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1383792017 |
ACTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 15, Platelet-type bleeding disorder 15 |
| RS1383795440 |
DEPDC5
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS138379977 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS1383803030 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS138380958 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Otospondylomegaepiphyseal dysplasia, autosomal recessive |
| RS138381632 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Cardiovascular phenotype |
| RS138381683 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, MSH3-related disorder |
| RS138381915 |
GRHL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Van der Woude syndrome 2, Inborn genetic diseases |
| RS1383819913 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS1383821738 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Kabuki syndrome |
| RS138382420 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Inborn genetic diseases |
| RS1383825118 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS138382534 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
LRP2-related disorder, LRP2-related disorder |
| RS1383826978 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS138382758 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2A2, Hereditary motor and sensory neuropathy with optic atrophy |
| RS138383101 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1383833874 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS138385061 |
ERCC3
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group B, Xeroderma pigmentosum |
| RS138386557 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS138386617 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS138386772 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS138387687 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS138387807 |
SLC10A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138387856 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS138387946 |
COPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune interstitial lung disease-arthritis syndrome, Inborn genetic diseases |
| RS138388301 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS138389072 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Congenital contractural arachnodactyly |
| RS1383907349 |
PDE6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 43 |
| RS138390862 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lissencephaly 9 with complex brainstem malformation, Inborn genetic diseases |
| RS1383911599 |
DISP1
|
Health Risk |
Likely pathogenic |
— |
| RS1383912514 |
XPA
|
Health Risk |
Pathogenic |
— |
| RS138391404 |
KCNJ8
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS138392504 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS138392588 |
MYOM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS138392909 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138393322 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS138393416 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS138394487 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DMXL2-related disorder |
| RS1383948929 |
GRM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138395184 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Fanconi anemia |
| RS138396764 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Spondylometaphyseal dysplasia |
| RS138396959 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS138397380 |
INTS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with cataracts, poor growth |
| RS138397457 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 12, Naxos disease |
| RS138398085 |
SEMA4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 10 |
| RS138398268 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
COG8-congenital disorder of glycosylation, Inborn genetic diseases |
| RS138398480 |
BICC1
|
Health Risk |
Conflicting classifications of pathogenicity |
BICC1-related disorder, BICC1-related disorder |
| RS1383985512 |
UNC45A
|
Health Risk |
Pathogenic |
Osteootohepatoenteric syndrome, Osteootohepatoenteric syndrome |
| RS138398760 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS138398778 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS138398782 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3 deficiency, Leigh syndrome |
| RS138398942 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138399473 |
AMER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS1384003425 |
UBQLN2
|
Health Risk |
Likely pathogenic |
— |
| RS138400599 |
ABHD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Triglyceride storage disease with ichthyosis, Triglyceride storage disease with ichthyosis |
| RS138400723 |
MATN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138401303 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1384021857 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1384034145 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1384034981 |
DBT
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1384040769 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1384042381 |
OCA2
|
Health Risk |
Likely pathogenic |
Albinism, Tyrosinase-positive oculocutaneous albinism |
| RS138404783 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic pain syndrome, familial |
| RS138405215 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1384052546 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KBG syndrome |
| RS138406248 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138406510 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N |
| RS138407155 |
APOA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoalphalipoproteinemia, primary |
| RS138407813 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1384084291 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis 4 |
| RS138409434 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS1384099162 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1384101598 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS138410865 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS138410893 |
PIGL
|
Health Risk |
Conflicting classifications of pathogenicity |
CHIME syndrome, CHIME syndrome |
| RS138410949 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Intellectual disability |
| RS138411530 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS138413231 |
PRAMEF4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1384133905 |
IDH3A
|
Health Risk |
Likely pathogenic |
— |
| RS138413501 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1384148842 |
TAF8
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with severe motor impairment, absent language |
| RS1384158714 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS138416154 |
PHKG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXc, PHKG2-related disorder |
| RS1384166265 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |